EN
English✓简体中文繁體中文TürkçeEspañolBahasa MelayuBahasa IndonesiaTiếng ViệtPortuguêsРусский

Only complete language versions are shown.

Let’s talk

Before returning home with mantle cell lymphoma: who will take over follow-up, medication, and urgent care arrangements

EastMedGo

Before returning home, confirm which local hospital and hematologist will take over your care, and write down your next tests, medication refills, and how to get help if problems arise. Even if you have been discharged or are in remission, you still need follow-up according to your individual plan; if you recently had a transplant or CAR-T, first ask your treatment team to assess whether you are fit to travel and when you can leave the country, and confirm emergency arrangements during your journey.

Key points

  • Before leaving the country, obtain a treatment summary and a written follow-up plan, and confirm the date of your first local appointment, the doctor, and where tests will be done.
  • Plans for maintenance treatment, oral medication, and monitoring after a transplant or CAR-T may differ, so do not copy someone else's follow-up intervals.
  • During chemotherapy, if your temperature reaches or exceeds 38°C, contact your treatment team immediately; if you cannot reach them, go to the nearest emergency department as soon as possible. If your doctor has told you to seek help sooner, follow your individual instructions.
  • Contact your team promptly if you have chills, a cough, diarrhea, painful urination, or redness and swelling around a catheter, even if you do not yet have a fever. Call local emergency services if you feel seriously unwell.

Confirm who will take over your care

Ask your treatment team in China to help prepare a referral summary and contact the hematology or oncology service that will care for you after you return home. Ask whether they can accept you, what referral or translation they require, and whether they can carry out your next tests and treatment; obtain the first appointment time and contact details. After sending the records, confirm that the receiving team can open them and knows what needs to be done. If you have not yet found a doctor to take over, ask your original team to help discuss an interim plan, so you do not leave the country before finding someone to take over your care.

Write down each team's responsibilities: which tests and medication decisions the local doctor will handle, whether the team in China can answer questions about previous treatment, and how the teams will share results. Confirm separately with the institutions whether they can provide cross-border remote advice and whether they can issue prescriptions valid locally.

Document your condition and next follow-up

The summary should list your pathology diagnosis, disease stage or risk information, the names and dates of all treatments, treatment response assessments and important side effects, and whether you are currently under observation, receiving maintenance treatment, or in another treatment phase. Keep the original pathology report, a complete treatment and medication timeline, recent blood test results, and imaging files; ask the receiving team what language, format, and secure transfer method they need. Record the date and result of your most recent treatment response assessment. Ask your doctor to specify the dates of your next clinic visit and tests, which results should be reviewed first and by whom, and whom to contact if results are delayed or appointments are rescheduled. Patients under observation also need scheduled follow-up and a way to report changes before their appointment; people continuing oral targeted medication or receiving maintenance infusions also need written details of the next dose, blood tests, and who will explain the results.

If you recently had a transplant or CAR-T, ask your original center before buying tickets to assess whether your condition allows travel, when you can leave the country, what care you will need during the journey, and where to go in an emergency. Confirm the transplant type or CAR-T product, treatment date, complications, preventive medications, follow-up, and emergency contact arrangements, and ask the local team to confirm whether they can take over this care; if they cannot, ask both teams to discuss referral to an appropriate facility. Observation requirements may differ between products and centers, and being discharged does not mean you are already fit for long-distance travel.

What does follow-up usually involve?

At follow-up visits, tell your local doctor about any recent changes in lumps, fever, night sweats, weight, abdominal discomfort, or energy levels; bring representative previous reports and details of how to access the original images. Your doctor will use your medical history, physical examination, blood tests, and any other necessary tests to decide what comes next. Do not decide on your own that the disease has relapsed based on a single result.

The 2025 guidelines from the European Hematology Association and the European MCL Network provide general guidance after first-line systemic treatment: medical history reviews, physical examinations, and blood tests are more frequent during the first two years, with intervals gradually increasing afterward; specific recommendations include approximately every 3–4 months for the first two years, approximately every 6 months for the next three years, and annually thereafter. This is not an individual schedule: arrangements may differ during treatment, with abnormal results or high-risk disease, or after cellular therapy, so ask your own hematology team to confirm the dates and tests. The guidelines do not recommend PET-CT for routine monitoring; your doctor will decide whether imaging is needed because of specific symptoms or test results.

Check medication refills and pending results

Check each medication's generic name, strength, directions for use, remaining supply, storage conditions, and next prescription date. Ask your local doctor or pharmacist whether the same medication is available, what prescription is required, the expected cost, and possible alternatives. If the strength or brand differs, ask your doctor and pharmacist to check it first; do not change medication or adjust the dose yourself. If you still need maintenance infusions, also confirm the receiving facility, testing requirements, and whom to contact if an infusion is delayed; when starting an anti-infective medicine or anticoagulant, or preparing for surgery, proactively inform your hematology team so they can review your medications. Check the rules for carrying medication in the places you will travel through, and ask your doctor or pharmacist to confirm the extra supply needed for delays and any special storage conditions. If you have received anti-CD20 treatment or a BTK inhibitor, or have a history of hepatitis B infection, ask your team to confirm your hepatitis B test results, whether prevention or monitoring is needed, who will be responsible after you return home, and when repeat tests are due. Your hematology team will decide the specific arrangements based on your individual treatment and infection history.

Make a separate list of pending pathology or other test results: the test, sample collection date, expected date to check for results, the person responsible for checking, and who will receive the results. Ask the receiving doctor to confirm whether the plan needs to change once the results arrive.

What to do if problems arise

Ask your doctor to write down your individual thresholds for action for fever, bleeding, and infection, daytime and nighttime contact numbers, and where to go for emergency care. Keep a working thermometer with you; during chemotherapy, check your temperature if you feel feverish, chilled, or unwell. During chemotherapy, if your temperature reaches or exceeds 38°C, contact your local treatment team immediately and seek care according to their emergency instructions; follow your doctor's instructions if they have told you to seek help sooner. If you develop a fever, contact your team immediately even if you have not yet been given an individual threshold; if you cannot reach them promptly, do not wait for a reply from abroad—go to the nearest emergency department as soon as possible. A fever during other treatment phases also requires immediate contact with your local team; if you cannot reach them, go to the nearest emergency department as soon as possible, and confirm specific thresholds and where to go in your individual plan.

Contact your team promptly for signs of infection such as chills, a cough, diarrhea, painful urination, or redness and swelling around a catheter, even if you do not yet have a fever; go to the nearest emergency department if symptoms are severe or worsen rapidly. Contact your hematology team promptly for persistent or repeated bleeding, blood in your urine, black or bloody stools, new unusual bruising, or pinpoint spots of bleeding under the skin; if you cannot reach them promptly, seek assessment at a local medical facility as soon as possible. Call local emergency services immediately for critical symptoms such as heavy bleeding or bleeding that will not stop, marked difficulty breathing, or changes in consciousness. At the emergency department, explain your lymphoma diagnosis and recent treatment; if you have had a transplant or CAR-T, also give the treatment date and the product or transplant type. Bring your medication list and summary, but do not delay care to look for documents.

If you have received CAR-T and develop fever, chills, or other warning symptoms listed by your original treatment center, contact the treatment center immediately and seek care according to its emergency plan; if you cannot reach them, go to the nearest emergency department as soon as possible. For new confusion, marked drowsiness, difficulty speaking, or seizures, go to a local emergency department or call local emergency services immediately; do not wait for a reply from abroad. Tell the medical staff that you have received CAR-T, the product name, and the infusion date; carry the warning card or written information provided by your treatment center, if available, but do not delay seeking help to look for these materials. Your original center needs to provide an individual observation, travel, and emergency plan based on the actual product and your condition.

Tell the team taking over your care promptly about new or worsening lumps, night sweats, weight changes, or fatigue. Record when they started, how they have changed, and any limits on your daily activities; you do not need to wait until your scheduled follow-up. Follow-up may include questions about symptoms, a physical examination, and blood tests; your doctor will decide whether imaging is needed based on your condition.

Hand over recovery and long-term health care to your local doctor too

Bring your vaccination records and discuss your immune status after treatment and a suitable vaccination schedule with your hematology team and local vaccination doctor; arrangements may differ after a transplant or immunosuppressive treatment, so do not decide on live vaccines or revaccination timing yourself. If you have persistent fatigue, sleep changes, emotional distress, or reduced physical stamina, explain what you could do before and how you are affected now, and ask your doctor to assess possible causes and discuss support.

Give your local doctor records of the medications, radiotherapy, or transplant you actually received, so they can discuss which late effects need attention based on your treatment exposures and individual circumstances. Have your local team assess new changes first; your doctor will decide whether new imaging or sampling is needed. Do not delay local care while trying to return abroad for an appointment.

Frequently asked questions

Do I still need an appointment if I have no symptoms now?

You need follow-up as arranged by your doctor. Appointment intervals depend on your condition and treatment; confirm your individual dates before leaving the hospital.

What if my local doctor cannot provide my original medication?

Tell both teams and your local pharmacist as early as possible so they can check medication availability and feasible options; do not stop medication yourself or substitute it based on similar packaging.

Is the handover complete once the results have been sent?

Ask the receiving team to confirm that the files are readable, the appointment is confirmed, and which doctor will review the results and provide feedback. If an emergency occurs while you are waiting for a reply, seek help locally first.

Should I wait until follow-up if I develop bruising or repeated bleeding?

Do not wait until your scheduled follow-up. Contact your hematology team promptly and explain the changes; if you cannot reach them promptly, seek assessment locally as soon as possible. For heavy bleeding or bleeding that will not stop, call local emergency services immediately.

Does a lump or an abnormal test result mean the disease has relapsed?

A single change is not enough to draw a conclusion. Tell your local hematology team about the change as soon as possible, so your doctor can decide whether further tests are needed based on your medical history.

When should I get vaccinated?

Bring your vaccination records and treatment plan so your hematology team and local vaccination doctor can decide based on your immune status, especially after a transplant or immunosuppressive treatment.

If the doctors disagree, whose advice should the family follow?

Ask the two doctors to explain their disagreement, the evidence behind their views, and the next steps, either directly or through formal channels; if there are urgent symptoms, have the local team manage them first.

Sources

Chat on WhatsAppEmail